PCN3- COMPARISON OF COSTS AND EFFECTS OF PROPHYLACTIC PAMIDRONATE FOR THE PREVENTION OF SKELETAL RELATED EVENTS IN PATIENTS WITH ADVANCED BREAST CANCER IN POLAND (COST-EFFECTIVENESS AND COST-UTILITY ANALYSIS)
Sep 1, 2000, 00:00 AM
10.1016/S1098-3015(11)70758-6
https://www.valueinhealthjournal.com/article/S1098-3015(11)70758-6/fulltext
Section Title :
Section Order :
141
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70758-6&doi=10.1016/S1098-3015(11)70758-6